SCHEMBL8431757

SCHEMBL8431757

COc1ccc2c(c1)C(CCn1ccnc1)=C(C)C2=Cc1ccc(S(N)(=O)=O)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA1 P00915 6/20 0.40
▸ CA2 P00918 6/20 0.40
▸ CA12 O43570 5/20 0.40
▸ CA4 P22748 5/20 0.40
▸ CA9 Q16790 5/20 0.40
▸ LMNA P02545 2/20 0.39
▸ MAPT P10636 2/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ CYP19A1 P11511 1/20 0.37
▸ LCK P06239 1/20 0.37
▸ HTR6 P50406 1/20 0.37
▸ CYP1A2 P05177 1/20 0.36
▸ GLA P06280 1/20 0.36
▸ CYP3A4 P08684 1/20 0.36
▸ TSHR P16473 1/20 0.36
▸ EDNRA P25101 1/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ PMP22 Q01453 1/20 0.36
▸ HIF1A Q16665 1/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8431618 0.83 CA2 (0.47) CA1CA2CA12CA4CA9
SCHEMBL8431755 0.78 LCK (0.37) CA1CA2CA12CA4CA9
SCHEMBL8603398 0.77 CYP1A2 (0.60) CA1CA2CA12CA4CA9
SCHEMBL10603249 0.77 CA2 (0.53) CA1CA2CA12CA4CA9
SCHEMBL8154670 0.73 CYP1A2 (0.53) MAPTLCKHTR6CYP1A2GLA
SCHEMBL8154671 0.73 CYP1A2 (0.53) MAPTLCKHTR6CYP1A2GLA
SCHEMBL10604073 0.71 CA2 (0.43) CA1CA2CA12CA4CA9
SCHEMBL10739215 0.71 CYP1A2 (0.57) CA1CA2CA12CA4CA9
SCHEMBL8431752 0.70 CYP19A1 (0.47) CA1CA2CA12CA4CA9
SCHEMBL2222358 0.68 CYP1A2 (0.73) LMNAMAPTALDH1A1CYP1A2GLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5965619-A ADMINISTERING AN INDENE DERIVATIVE OF GIVEN FORMULA, SUCH AS 1-(2,4,6-TRIMETHOXYBENZYLIDENE)-5-DIMETHYLAMINO-2-METHYL-3-INDENYL ACETIC ACID, TO TREAT PRECANCEROUS LESIONS SUCH AS COLONIC ADENOMATOUS POLYPS; SIDE EFFECT REDUCTION CELL PATHWAYS INC. (US) 1999-10-12 — — US disclosed
US-4656190-A PLATELET ACTIVATING FACTOR MERCK & CO., INC. (US) 1987-04-07 — — US disclosed
EP-0142801-A2 Indene derivatives useful as paf-antagonists MERCK & CO. INC. (US) 1985-05-29 — — EP disclosed
Send feedback